1. Colorectal Cancer Surgery During the COVID-19 Pandemic: A Single Center Experience
- Author
-
Lorenzo Epis, Davide Pertile, Stefano Scabini, Alessandra Aprile, Andrea Massobrio, Marco Gipponi, Carol Marzia Ferrari, Paola Batistotti, and Domenico Soriero
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,Colorectal cancer ,Medical Oncology ,Single Center ,General Biochemistry, Genetics and Molecular Biology ,Health care ,Pandemic ,medicine ,Humans ,Elective surgery ,Pandemics ,Aged ,Aged, 80 and over ,Pharmacology ,SARS-CoV-2 ,business.industry ,COVID-19 ,Middle Aged ,medicine.disease ,Colorectal surgery ,Hospitalization ,Elective Surgical Procedures ,Emergency medicine ,Female ,Colorectal Neoplasms ,Elective Surgical Procedure ,business ,Research Article - Abstract
Background/aim A notable re-allocation of healthcare resources and specific clinical and organizational measures have been required to prevent COVID-19 infection among hospitalized patients and healthcare workers. Patients and methods From March 9th to May 9th 2020 we performed colorectal cancer elective surgery on 25 patients: a pre-hospital screening was carried out in order to avoid hospitalization of patients suspected of COVID-19 infection. Results All patients (median age=76 years; range=37-88 years) were considered suitable for admission after telephone triage; the median interval between primary diagnosis and hospital admission was 23.1 days (range=1-55 days). The median hospitalization was 7.8 days (range=4-18 days). One COVID-19-associated death was reported. Conclusion Our experience demonstrates that safe colorectal cancer elective surgery can be performed during the pandemic COVID-19. Further consensus and guidelines to prevent diffusion of pandemic diseases among hospitalized patients and healthcare workers still need to be implemented.
- Published
- 2021
- Full Text
- View/download PDF